Introducing MosaiQ™ by Quotient
Better matched blood = better patient care.
MosaiQ will be the world’s first fully-automated testing solution that will allow for rapid, extensive antigen typing and antibody identification of donor and patient blood utilizing a single microarray. The extended phenotyping capabilities will enable better matched blood and reduced risk of alloimmunization. This will in turn provide patients with timely delivery of safe and compatible blood products.
Operating on a fully automated, consolidated platform, MosaiQ will offer the potential for improved clinical decision making and considerable operating efficiencies, both in a donor and patient testing environments.
Designed to be a comprehensive automated testing solution with the goal to establish new standards of excellence in transfusion medicine worldwide.
The MosaiQ platform has the goal of enabling:
- Comprehensive characterization of donor blood using just a single blood sample
- Increased workflow efficiencies through walk-away-capable processing of 1000 microarrays in a single 8-hour shift
- Enhanced resource management capabilities from a platform designed for ease of use, simplified reagent and consumable needs
- Reliable and reproducible results